number of downloads : ?
language
eng
Author
Michihiro Hide Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
Hae-Sim Park Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea
Atsuyuki Igarashi Department of Dermatology, NTT Medical Center Tokyo, Tokyo, Japan
Young-Min Ye Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea
Tae-Bum Kim Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Akiko Yagami Department of Dermatology, Fujita Health University School of Medicine, Toyoake, Japan
Jooyoung Roh Department of Dermatology, Gachon University Gil Medical Center, Incheon, Korea
Jae-Hyun Lee Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea
Woong Youn Sang Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea
Soo-Keol Lee Department of Internal Medicine, Dong-A University School of Medicine, Busan, Korea
Naoko Inomata Department of Environmental Immuno-Dermatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan
Jeong-Hee Choi Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea
Atsushi Fukunaga Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan
Junyi Wang Novartis Pharma K.K., Tokyo, Japan
Soichiro Matsushima Novartis Pharma K.K., Tokyo, Japan
Steve Greenberg Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
Sam Khalil Novartis Pharma AG, Basel, Switzerland
Subject
Antihistamines; Chronic spontaneous urticaria; Japan; Korea; Omalizumab
Journal Title
JOURNAL OF DERMATOLOGICAL SCIENCE
Volume
87
Issue
1
Start Page
70
End Page
78
ISSN
0923-1811
ISSN(Online)
1873-569X
Published Date
2017-07
DOI
PubMed ID
Publisher
ELSEVIER IRELAND LTD
NII Type
Journal Article
OAI-PMH Set
Faculty of Medicine
Remark
This study was funded by Novartis Pharmaceuticals.
このエントリーをはてなブックマークに追加